
Sign up to save your podcasts
Or


Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.
By The European Committee for Treatment and Research in Multiple Sclerosis4.5
22 ratings
Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.

299 Listeners

53 Listeners

28,143 Listeners

113,121 Listeners

150 Listeners

898 Listeners

51 Listeners

5,217 Listeners

6,097 Listeners

125 Listeners

2,131 Listeners

80 Listeners